Table 7.

Descriptive statistics for the parafoveal mean DVD (%) in the study participants by selected clinical conditions (n = 28).

Investigated Trait	Statistical Parameter		p-Value
	M (SD)	Me (Q1–Q3)
Localized scleroderma	42.55 (1.44)	42.34 (41.46–43.93)	=0.6199
Systemic scleroderma	42.21 (2.47)	42.12 (41.15–43.90)
Scleroderma pattern:			=0.4437
●   Early	41.57 (4.02)	43.54 (39.21–44.06)
●   Active	42.51 (1.50)	42.04 (41.47–43.80)
●   Late	42.08 (1.70)	41.22 (41.07–44.38)
SCI70	42.01 (2.64)	42.04 (40.94–44.09)	=0.6192
Centromere	42.55 (1.44)	42.34 (41.46–43.93)
Number of vessels:			=0.3402
Normal	43.84 (0.52)	43.84 (43.40–44.29)
Reduced	42.24 (2.35)	42.44 (41.36–43.85)
Very reduced	41.99 (1.60)	41.47 (41.22–41.63)
Avascular areas:			=0.7687
●   Yes	42.42 (1.49)	41.76 (41.22–43.75)
●   No	42.23 (2.76)	43.05 (41.45–44.25)
Giant capillaries:			=0.3396
●   Yes	42.65 (1.51)	42.44 (41.47–43.90)
●   No	42.03 (2.62)	42.00 (41.15–44.23)
Hemorrhages:			=0.8356
●   Yes	42.42 (1.23)	42.10 (41.49–43.55)
●   No	42.28 (2.54)	43.05 (41.22–44.35)
Branched vessels:			=0.1093
●   Yes	43.14 (1.32)	43.38 (42.12–43.90)
●   No	42.00 (2.34)	41.69 (41.19–43.93)
Interstitial lung disease:			=0.2237
●   Yes	42.92 (1.73)	43.54 (41.07–44.38)
●   No	42.07 (2.29)	42.00 (41.27–43.63)
NSIP	43.58 (1.50)	43.80 (43.37–44.45)	=0.1244
UIP	41.46 (1.66)	40.82 (40.44–42.49)
MMF	41.88 (2.79)	42.13 (41.22–43.70)	=0.5305
MTX	42.70 (1.63)	43.35 (41.47–44.25)
Finger ulcers:			=0.8485
●   Yes	42.42 (1.54)	42.10 (41.07–43.70)
●   No	42.28 (2.43)	42.47 (41.27–44.25)
Arterial hypertension:			=0.9677
●   Yes	42.31 (1.78)	41.61 (41.45–44.45)
●   No	42.28 (2.32)	41.12 (41.22–43.90)
Administration of sildenafil:			=0.8966
●   Yes	42.23 (1.45)	41.94 (41.07–43.48)
●   No	42.32 (2.62)	42.95 (41.47–44.35)
Administration of amlodipine:			=0.3429
●   Yes	41.95 (2.64)	41.72 (41.47–44.23)
●   No	42.59 (1.64)	42.44 (41.15–43.90)

M—mean; SD—standard deviation; Me—median; Q—quartile.